nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—Exemestane—Prednisone—psoriasis	0.121	0.339	CrCrCtD
Estropipate—Exemestane—Prednisolone—psoriasis	0.118	0.331	CrCrCtD
Estropipate—Formestane—Hydrocortisone—psoriasis	0.117	0.33	CrCrCtD
Estropipate—SHBG—Hydrocortisone—psoriasis	0.0951	0.216	CbGbCtD
Estropipate—ALB—Acitretin—psoriasis	0.0599	0.136	CbGbCtD
Estropipate—CYP1A2—Clobetasol propionate—psoriasis	0.0556	0.126	CbGbCtD
Estropipate—CYP1A2—Methoxsalen—psoriasis	0.0292	0.0663	CbGbCtD
Estropipate—ALB—Mycophenolate mofetil—psoriasis	0.0281	0.0636	CbGbCtD
Estropipate—ALB—Prednisone—psoriasis	0.0224	0.0509	CbGbCtD
Estropipate—CYP3A4—Calcitriol—psoriasis	0.0197	0.0447	CbGbCtD
Estropipate—CYP2C9—Cholecalciferol—psoriasis	0.0174	0.0396	CbGbCtD
Estropipate—CYP3A4—Methoxsalen—psoriasis	0.0153	0.0347	CbGbCtD
Estropipate—CYP2C9—Cyclosporine—psoriasis	0.0115	0.026	CbGbCtD
Estropipate—ALB—Methotrexate—psoriasis	0.0113	0.0255	CbGbCtD
Estropipate—CYP3A4—Cholecalciferol—psoriasis	0.0101	0.023	CbGbCtD
Estropipate—CYP3A4—Mycophenolate mofetil—psoriasis	0.0088	0.0199	CbGbCtD
Estropipate—CYP3A4—Triamcinolone—psoriasis	0.0088	0.0199	CbGbCtD
Estropipate—CYP2C9—Dexamethasone—psoriasis	0.00755	0.0171	CbGbCtD
Estropipate—CYP3A4—Betamethasone—psoriasis	0.00755	0.0171	CbGbCtD
Estropipate—CYP3A4—Prednisolone—psoriasis	0.00745	0.0169	CbGbCtD
Estropipate—CYP3A4—Hydrocortisone—psoriasis	0.00706	0.016	CbGbCtD
Estropipate—CYP3A4—Prednisone—psoriasis	0.00703	0.0159	CbGbCtD
Estropipate—CYP3A4—Cyclosporine—psoriasis	0.00667	0.0151	CbGbCtD
Estropipate—CYP3A4—Dexamethasone—psoriasis	0.00439	0.00995	CbGbCtD
Estropipate—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000781	0.0495	CbGpPWpGaD
Estropipate—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000484	0.0307	CbGpPWpGaD
Estropipate—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000414	0.0262	CbGpPWpGaD
Estropipate—ESR2—Ovarian Infertility Genes—VDR—psoriasis	0.000389	0.0247	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000368	0.0233	CbGpPWpGaD
Estropipate—ESR2—Nuclear Receptors—VDR—psoriasis	0.000339	0.0215	CbGpPWpGaD
Estropipate—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000319	0.0202	CbGpPWpGaD
Estropipate—ESR2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000268	0.017	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000264	0.0168	CbGpPWpGaD
Estropipate—ESR2—Nuclear Receptors—PPARG—psoriasis	0.000236	0.015	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000216	0.0137	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000203	0.0129	CbGpPWpGaD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000201	0.0127	CbGpPWpGaD
Estropipate—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000199	0.0126	CbGpPWpGaD
Estropipate—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000199	0.0126	CbGpPWpGaD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.000198	0.0126	CbGpPWpGaD
Estropipate—ESR2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000187	0.0118	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000184	0.0117	CbGpPWpGaD
Estropipate—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000174	0.011	CbGpPWpGaD
Estropipate—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000173	0.0109	CbGpPWpGaD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000172	0.0109	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptors—VDR—psoriasis	0.000171	0.0108	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL13—psoriasis	0.00017	0.0108	CbGpPWpGaD
Estropipate—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00017	0.0108	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—REL—psoriasis	0.000169	0.0107	CbGpPWpGaD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000163	0.0103	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000147	0.00934	CbGpPWpGaD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000139	0.00883	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000136	0.00863	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000135	0.00857	CbGpPWpGaD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000133	0.00841	CbGpPWpGaD
Estropipate—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000131	0.0083	CbGpPWpGaD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000128	0.00812	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—JUN—psoriasis	0.000126	0.00801	CbGpPWpGaD
Estropipate—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	0.000122	0.00771	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptors—PPARG—psoriasis	0.000119	0.00756	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—TARS—psoriasis	0.000119	0.00752	CbGpPWpGaD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	0.000111	0.007	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000108	0.00682	CbGpPWpGaD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL10—psoriasis	0.000107	0.00676	CbGpPWpGaD
Estropipate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000106	0.00672	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000102	0.00649	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL10—psoriasis	0.000102	0.00647	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	0.0001	0.00634	CbGpPWpGaD
Estropipate—ALB—Lipoprotein metabolism—APOE—psoriasis	9.99e-05	0.00633	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL4—psoriasis	9.93e-05	0.00629	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	9.42e-05	0.00597	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	9.33e-05	0.00592	CbGpPWpGaD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.24e-05	0.00586	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	9.08e-05	0.00576	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	9.03e-05	0.00572	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	8.99e-05	0.0057	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	8.97e-05	0.00569	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—CYP2S1—psoriasis	8.66e-05	0.00549	CbGpPWpGaD
Estropipate—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	8.54e-05	0.00541	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	8.46e-05	0.00045	CcSEcCtD
Estropipate—Anaphylactic shock—Hydrocortisone—psoriasis	8.46e-05	0.00045	CcSEcCtD
Estropipate—Oedema—Hydrocortisone—psoriasis	8.46e-05	0.00045	CcSEcCtD
Estropipate—Asthenia—Mycophenolic acid—psoriasis	8.44e-05	0.000449	CcSEcCtD
Estropipate—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	8.42e-05	0.00534	CbGpPWpGaD
Estropipate—Infection—Hydrocortisone—psoriasis	8.4e-05	0.000447	CcSEcCtD
Estropipate—Insomnia—Mycophenolate mofetil—psoriasis	8.39e-05	0.000446	CcSEcCtD
Estropipate—Dyspepsia—Cyclosporine—psoriasis	8.38e-05	0.000445	CcSEcCtD
Estropipate—Nausea—Hydroxyurea—psoriasis	8.34e-05	0.000444	CcSEcCtD
Estropipate—Paraesthesia—Mycophenolate mofetil—psoriasis	8.33e-05	0.000443	CcSEcCtD
Estropipate—Pruritus—Mycophenolic acid—psoriasis	8.32e-05	0.000443	CcSEcCtD
Estropipate—Myalgia—Triamcinolone—psoriasis	8.31e-05	0.000442	CcSEcCtD
Estropipate—Nervous system disorder—Hydrocortisone—psoriasis	8.29e-05	0.000441	CcSEcCtD
Estropipate—Eye disorder—Prednisone—psoriasis	8.28e-05	0.00044	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	8.27e-05	0.00524	CbGpPWpGaD
Estropipate—Somnolence—Mycophenolate mofetil—psoriasis	8.25e-05	0.000439	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	8.25e-05	0.00523	CbGpPWpGaD
Estropipate—Infestation NOS—Methotrexate—psoriasis	8.24e-05	0.000438	CcSEcCtD
Estropipate—Infestation—Methotrexate—psoriasis	8.24e-05	0.000438	CcSEcCtD
Estropipate—Depression—Methotrexate—psoriasis	8.22e-05	0.000437	CcSEcCtD
Estropipate—Gastrointestinal disorder—Cyclosporine—psoriasis	8.21e-05	0.000437	CcSEcCtD
Estropipate—Skin disorder—Hydrocortisone—psoriasis	8.21e-05	0.000437	CcSEcCtD
Estropipate—Fatigue—Cyclosporine—psoriasis	8.2e-05	0.000436	CcSEcCtD
Estropipate—Dyspepsia—Mycophenolate mofetil—psoriasis	8.17e-05	0.000435	CcSEcCtD
Estropipate—ALB—Hemostasis—SERPINB8—psoriasis	8.15e-05	0.00516	CbGpPWpGaD
Estropipate—Constipation—Cyclosporine—psoriasis	8.14e-05	0.000433	CcSEcCtD
Estropipate—Pain—Cyclosporine—psoriasis	8.14e-05	0.000433	CcSEcCtD
Estropipate—Angioedema—Dexamethasone—psoriasis	8.09e-05	0.00043	CcSEcCtD
Estropipate—Angioedema—Betamethasone—psoriasis	8.09e-05	0.00043	CcSEcCtD
Estropipate—Diarrhoea—Mycophenolic acid—psoriasis	8.05e-05	0.000428	CcSEcCtD
Estropipate—Angiopathy—Prednisone—psoriasis	8.03e-05	0.000427	CcSEcCtD
Estropipate—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	8.01e-05	0.000426	CcSEcCtD
Estropipate—Immune system disorder—Prednisone—psoriasis	8e-05	0.000425	CcSEcCtD
Estropipate—Oedema—Triamcinolone—psoriasis	7.96e-05	0.000423	CcSEcCtD
Estropipate—Anaphylactic shock—Triamcinolone—psoriasis	7.96e-05	0.000423	CcSEcCtD
Estropipate—Vertigo—Betamethasone—psoriasis	7.95e-05	0.000423	CcSEcCtD
Estropipate—Vertigo—Dexamethasone—psoriasis	7.95e-05	0.000423	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—LEP—psoriasis	7.95e-05	0.00504	CbGpPWpGaD
Estropipate—Pain—Mycophenolate mofetil—psoriasis	7.94e-05	0.000422	CcSEcCtD
Estropipate—Constipation—Mycophenolate mofetil—psoriasis	7.94e-05	0.000422	CcSEcCtD
Estropipate—Infection—Triamcinolone—psoriasis	7.91e-05	0.000421	CcSEcCtD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.9e-05	0.005	CbGpPWpGaD
Estropipate—Insomnia—Prednisolone—psoriasis	7.83e-05	0.000416	CcSEcCtD
Estropipate—Alopecia—Prednisone—psoriasis	7.83e-05	0.000416	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—psoriasis	7.8e-05	0.000415	CcSEcCtD
Estropipate—Gastrointestinal pain—Cyclosporine—psoriasis	7.78e-05	0.000414	CcSEcCtD
Estropipate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	7.78e-05	0.00493	CbGpPWpGaD
Estropipate—Dizziness—Mycophenolic acid—psoriasis	7.78e-05	0.000414	CcSEcCtD
Estropipate—Paraesthesia—Prednisolone—psoriasis	7.77e-05	0.000413	CcSEcCtD
Estropipate—Mental disorder—Prednisone—psoriasis	7.76e-05	0.000413	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—CARM1—psoriasis	7.75e-05	0.00491	CbGpPWpGaD
Estropipate—Erythema—Prednisone—psoriasis	7.71e-05	0.00041	CcSEcCtD
Estropipate—Malnutrition—Prednisone—psoriasis	7.71e-05	0.00041	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Hydrocortisone—psoriasis	7.7e-05	0.00041	CcSEcCtD
Estropipate—Insomnia—Hydrocortisone—psoriasis	7.65e-05	0.000407	CcSEcCtD
Estropipate—Paraesthesia—Hydrocortisone—psoriasis	7.59e-05	0.000404	CcSEcCtD
Estropipate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	7.59e-05	0.000404	CcSEcCtD
Estropipate—Urticaria—Cyclosporine—psoriasis	7.56e-05	0.000402	CcSEcCtD
Estropipate—Myalgia—Betamethasone—psoriasis	7.54e-05	0.000401	CcSEcCtD
Estropipate—Myalgia—Dexamethasone—psoriasis	7.54e-05	0.000401	CcSEcCtD
Estropipate—Abdominal pain—Cyclosporine—psoriasis	7.52e-05	0.0004	CcSEcCtD
Estropipate—Body temperature increased—Cyclosporine—psoriasis	7.52e-05	0.0004	CcSEcCtD
Estropipate—ESR1—FOXA1 transcription factor network—JUN—psoriasis	7.52e-05	0.00477	CbGpPWpGaD
Estropipate—Anxiety—Dexamethasone—psoriasis	7.51e-05	0.000399	CcSEcCtD
Estropipate—Anxiety—Betamethasone—psoriasis	7.51e-05	0.000399	CcSEcCtD
Estropipate—Vomiting—Mycophenolic acid—psoriasis	7.48e-05	0.000398	CcSEcCtD
Estropipate—Dyspepsia—Hydrocortisone—psoriasis	7.44e-05	0.000396	CcSEcCtD
Estropipate—Rash—Mycophenolic acid—psoriasis	7.42e-05	0.000394	CcSEcCtD
Estropipate—Dermatitis—Mycophenolic acid—psoriasis	7.41e-05	0.000394	CcSEcCtD
Estropipate—Pain—Prednisolone—psoriasis	7.4e-05	0.000394	CcSEcCtD
Estropipate—CYP1A2—Biological oxidations—CYP2S1—psoriasis	7.4e-05	0.00469	CbGpPWpGaD
Estropipate—Urticaria—Mycophenolate mofetil—psoriasis	7.37e-05	0.000392	CcSEcCtD
Estropipate—Headache—Mycophenolic acid—psoriasis	7.37e-05	0.000392	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—psoriasis	7.35e-05	0.000391	CcSEcCtD
Estropipate—Abdominal pain—Mycophenolate mofetil—psoriasis	7.34e-05	0.00039	CcSEcCtD
Estropipate—Body temperature increased—Mycophenolate mofetil—psoriasis	7.34e-05	0.00039	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	7.3e-05	0.00463	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.3e-05	0.000388	CcSEcCtD
Estropipate—Fatigue—Hydrocortisone—psoriasis	7.29e-05	0.000388	CcSEcCtD
Estropipate—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	7.29e-05	0.00462	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.25e-05	0.000386	CcSEcCtD
Estropipate—Pain—Hydrocortisone—psoriasis	7.23e-05	0.000385	CcSEcCtD
Estropipate—Oedema—Betamethasone—psoriasis	7.22e-05	0.000384	CcSEcCtD
Estropipate—Anaphylactic shock—Dexamethasone—psoriasis	7.22e-05	0.000384	CcSEcCtD
Estropipate—Anaphylactic shock—Betamethasone—psoriasis	7.22e-05	0.000384	CcSEcCtD
Estropipate—Oedema—Dexamethasone—psoriasis	7.22e-05	0.000384	CcSEcCtD
Estropipate—Insomnia—Triamcinolone—psoriasis	7.2e-05	0.000383	CcSEcCtD
Estropipate—Infection—Betamethasone—psoriasis	7.18e-05	0.000382	CcSEcCtD
Estropipate—Infection—Dexamethasone—psoriasis	7.18e-05	0.000382	CcSEcCtD
Estropipate—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	7.18e-05	0.00455	CbGpPWpGaD
Estropipate—Paraesthesia—Triamcinolone—psoriasis	7.15e-05	0.00038	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—psoriasis	7.13e-05	0.000379	CcSEcCtD
Estropipate—Nervous system disorder—Dexamethasone—psoriasis	7.08e-05	0.000377	CcSEcCtD
Estropipate—Nervous system disorder—Betamethasone—psoriasis	7.08e-05	0.000377	CcSEcCtD
Estropipate—Angioedema—Prednisone—psoriasis	7.04e-05	0.000375	CcSEcCtD
Estropipate—Hypersensitivity—Cyclosporine—psoriasis	7.01e-05	0.000373	CcSEcCtD
Estropipate—Dyspepsia—Triamcinolone—psoriasis	7.01e-05	0.000373	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—psoriasis	7e-05	0.000372	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.99e-05	0.00443	CbGpPWpGaD
Estropipate—Nausea—Mycophenolic acid—psoriasis	6.99e-05	0.000372	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.95e-05	0.00441	CbGpPWpGaD
Estropipate—Vertigo—Prednisone—psoriasis	6.93e-05	0.000368	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—psoriasis	6.92e-05	0.000368	CcSEcCtD
Estropipate—Gastrointestinal pain—Hydrocortisone—psoriasis	6.91e-05	0.000368	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	6.88e-05	0.00436	CbGpPWpGaD
Estropipate—Urticaria—Prednisolone—psoriasis	6.88e-05	0.000366	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—psoriasis	6.87e-05	0.000365	CcSEcCtD
Estropipate—Fatigue—Triamcinolone—psoriasis	6.86e-05	0.000365	CcSEcCtD
Estropipate—ALB—Folate Metabolism—CAT—psoriasis	6.84e-05	0.00434	CbGpPWpGaD
Estropipate—Hypersensitivity—Mycophenolate mofetil—psoriasis	6.84e-05	0.000364	CcSEcCtD
Estropipate—Asthenia—Cyclosporine—psoriasis	6.83e-05	0.000363	CcSEcCtD
Estropipate—Pain—Triamcinolone—psoriasis	6.81e-05	0.000362	CcSEcCtD
Estropipate—Pruritus—Cyclosporine—psoriasis	6.73e-05	0.000358	CcSEcCtD
Estropipate—Urticaria—Hydrocortisone—psoriasis	6.72e-05	0.000357	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—psoriasis	6.71e-05	0.000357	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—psoriasis	6.68e-05	0.000356	CcSEcCtD
Estropipate—Abdominal pain—Hydrocortisone—psoriasis	6.68e-05	0.000356	CcSEcCtD
Estropipate—Body temperature increased—Hydrocortisone—psoriasis	6.68e-05	0.000356	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—CRP—psoriasis	6.67e-05	0.00423	CbGpPWpGaD
Estropipate—Mediastinal disorder—Methotrexate—psoriasis	6.67e-05	0.000355	CcSEcCtD
Estropipate—Asthenia—Mycophenolate mofetil—psoriasis	6.66e-05	0.000354	CcSEcCtD
Estropipate—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	6.64e-05	0.00421	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Betamethasone—psoriasis	6.58e-05	0.00035	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.58e-05	0.00035	CcSEcCtD
Estropipate—Pruritus—Mycophenolate mofetil—psoriasis	6.57e-05	0.000349	CcSEcCtD
Estropipate—Myalgia—Prednisone—psoriasis	6.56e-05	0.000349	CcSEcCtD
Estropipate—Arthralgia—Prednisone—psoriasis	6.56e-05	0.000349	CcSEcCtD
Estropipate—Anxiety—Prednisone—psoriasis	6.54e-05	0.000348	CcSEcCtD
Estropipate—Alopecia—Methotrexate—psoriasis	6.54e-05	0.000348	CcSEcCtD
Estropipate—Insomnia—Dexamethasone—psoriasis	6.53e-05	0.000348	CcSEcCtD
Estropipate—Insomnia—Betamethasone—psoriasis	6.53e-05	0.000348	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—APOE—psoriasis	6.53e-05	0.00414	CbGpPWpGaD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.52e-05	0.000347	CcSEcCtD
Estropipate—Diarrhoea—Cyclosporine—psoriasis	6.51e-05	0.000346	CcSEcCtD
Estropipate—Paraesthesia—Betamethasone—psoriasis	6.49e-05	0.000345	CcSEcCtD
Estropipate—Paraesthesia—Dexamethasone—psoriasis	6.49e-05	0.000345	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—psoriasis	6.48e-05	0.000345	CcSEcCtD
Estropipate—Erythema—Methotrexate—psoriasis	6.44e-05	0.000343	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—psoriasis	6.44e-05	0.000343	CcSEcCtD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.44e-05	0.00408	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	6.4e-05	0.00405	CbGpPWpGaD
Estropipate—CYP1A2—Tryptophan metabolism—CAT—psoriasis	6.39e-05	0.00405	CbGpPWpGaD
Estropipate—Hypersensitivity—Prednisolone—psoriasis	6.38e-05	0.000339	CcSEcCtD
Estropipate—Dyspepsia—Betamethasone—psoriasis	6.36e-05	0.000338	CcSEcCtD
Estropipate—Dyspepsia—Dexamethasone—psoriasis	6.36e-05	0.000338	CcSEcCtD
Estropipate—Diarrhoea—Mycophenolate mofetil—psoriasis	6.35e-05	0.000338	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.34e-05	0.00402	CbGpPWpGaD
Estropipate—Urticaria—Triamcinolone—psoriasis	6.33e-05	0.000336	CcSEcCtD
Estropipate—Body temperature increased—Triamcinolone—psoriasis	6.29e-05	0.000335	CcSEcCtD
Estropipate—Dizziness—Cyclosporine—psoriasis	6.29e-05	0.000335	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—psoriasis	6.29e-05	0.000335	CcSEcCtD
Estropipate—Oedema—Prednisone—psoriasis	6.29e-05	0.000335	CcSEcCtD
Estropipate—ALB—Folate Metabolism—IL4—psoriasis	6.28e-05	0.00398	CbGpPWpGaD
Estropipate—Infection—Prednisone—psoriasis	6.25e-05	0.000332	CcSEcCtD
Estropipate—Gastrointestinal disorder—Betamethasone—psoriasis	6.24e-05	0.000332	CcSEcCtD
Estropipate—Gastrointestinal disorder—Dexamethasone—psoriasis	6.24e-05	0.000332	CcSEcCtD
Estropipate—Back pain—Methotrexate—psoriasis	6.23e-05	0.000331	CcSEcCtD
Estropipate—Hypersensitivity—Hydrocortisone—psoriasis	6.23e-05	0.000331	CcSEcCtD
Estropipate—Fatigue—Betamethasone—psoriasis	6.23e-05	0.000331	CcSEcCtD
Estropipate—Fatigue—Dexamethasone—psoriasis	6.23e-05	0.000331	CcSEcCtD
Estropipate—Pain—Betamethasone—psoriasis	6.18e-05	0.000329	CcSEcCtD
Estropipate—Pain—Dexamethasone—psoriasis	6.18e-05	0.000329	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—psoriasis	6.17e-05	0.000328	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—IFNG—psoriasis	6.14e-05	0.00389	CbGpPWpGaD
Estropipate—Dizziness—Mycophenolate mofetil—psoriasis	6.14e-05	0.000326	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	6.13e-05	0.00389	CbGpPWpGaD
Estropipate—Skin disorder—Prednisone—psoriasis	6.11e-05	0.000325	CcSEcCtD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.09e-05	0.00386	CbGpPWpGaD
Estropipate—Asthenia—Hydrocortisone—psoriasis	6.07e-05	0.000323	CcSEcCtD
Estropipate—Vomiting—Cyclosporine—psoriasis	6.05e-05	0.000322	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—IFNG—psoriasis	6e-05	0.0038	CbGpPWpGaD
Estropipate—Rash—Cyclosporine—psoriasis	6e-05	0.000319	CcSEcCtD
Estropipate—Dermatitis—Cyclosporine—psoriasis	5.99e-05	0.000319	CcSEcCtD
Estropipate—Pruritus—Hydrocortisone—psoriasis	5.98e-05	0.000318	CcSEcCtD
Estropipate—ESR1—Gene Expression—TARS—psoriasis	5.98e-05	0.00379	CbGpPWpGaD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	5.96e-05	0.00378	CbGpPWpGaD
Estropipate—Headache—Cyclosporine—psoriasis	5.96e-05	0.000317	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—JUN—psoriasis	5.95e-05	0.00377	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Dexamethasone—psoriasis	5.91e-05	0.000314	CcSEcCtD
Estropipate—Gastrointestinal pain—Betamethasone—psoriasis	5.91e-05	0.000314	CcSEcCtD
Estropipate—Vomiting—Mycophenolate mofetil—psoriasis	5.9e-05	0.000314	CcSEcCtD
Estropipate—Hypersensitivity—Triamcinolone—psoriasis	5.87e-05	0.000312	CcSEcCtD
Estropipate—Rash—Mycophenolate mofetil—psoriasis	5.85e-05	0.000311	CcSEcCtD
Estropipate—Dermatitis—Mycophenolate mofetil—psoriasis	5.85e-05	0.000311	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.83e-05	0.00369	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	5.82e-05	0.00369	CbGpPWpGaD
Estropipate—Headache—Mycophenolate mofetil—psoriasis	5.81e-05	0.000309	CcSEcCtD
Estropipate—Vertigo—Methotrexate—psoriasis	5.79e-05	0.000308	CcSEcCtD
Estropipate—Diarrhoea—Hydrocortisone—psoriasis	5.79e-05	0.000308	CcSEcCtD
Estropipate—Urticaria—Dexamethasone—psoriasis	5.74e-05	0.000305	CcSEcCtD
Estropipate—Urticaria—Betamethasone—psoriasis	5.74e-05	0.000305	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—psoriasis	5.73e-05	0.000305	CcSEcCtD
Estropipate—Dizziness—Prednisolone—psoriasis	5.73e-05	0.000305	CcSEcCtD
Estropipate—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.71e-05	0.00362	CbGpPWpGaD
Estropipate—Asthenia—Triamcinolone—psoriasis	5.71e-05	0.000304	CcSEcCtD
Estropipate—Abdominal pain—Dexamethasone—psoriasis	5.71e-05	0.000304	CcSEcCtD
Estropipate—Body temperature increased—Betamethasone—psoriasis	5.71e-05	0.000304	CcSEcCtD
Estropipate—Abdominal pain—Betamethasone—psoriasis	5.71e-05	0.000304	CcSEcCtD
Estropipate—Body temperature increased—Dexamethasone—psoriasis	5.71e-05	0.000304	CcSEcCtD
Estropipate—Insomnia—Prednisone—psoriasis	5.69e-05	0.000303	CcSEcCtD
Estropipate—Nausea—Cyclosporine—psoriasis	5.65e-05	0.000301	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—psoriasis	5.65e-05	0.0003	CcSEcCtD
Estropipate—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.63e-05	0.00357	CbGpPWpGaD
Estropipate—Pruritus—Triamcinolone—psoriasis	5.63e-05	0.0003	CcSEcCtD
Estropipate—Cough—Methotrexate—psoriasis	5.62e-05	0.000299	CcSEcCtD
Estropipate—Dizziness—Hydrocortisone—psoriasis	5.59e-05	0.000297	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	5.58e-05	0.00354	CbGpPWpGaD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	5.57e-05	0.00353	CbGpPWpGaD
Estropipate—Dyspepsia—Prednisone—psoriasis	5.54e-05	0.000295	CcSEcCtD
Estropipate—Nausea—Mycophenolate mofetil—psoriasis	5.51e-05	0.000293	CcSEcCtD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.5e-05	0.00349	CbGpPWpGaD
Estropipate—Arthralgia—Methotrexate—psoriasis	5.48e-05	0.000292	CcSEcCtD
Estropipate—Myalgia—Methotrexate—psoriasis	5.48e-05	0.000292	CcSEcCtD
Estropipate—Rash—Prednisolone—psoriasis	5.46e-05	0.00029	CcSEcCtD
Estropipate—Dermatitis—Prednisolone—psoriasis	5.45e-05	0.00029	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.45e-05	0.00029	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.43e-05	0.00344	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—CAT—psoriasis	5.43e-05	0.00344	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—CRP—psoriasis	5.43e-05	0.00344	CbGpPWpGaD
Estropipate—Fatigue—Prednisone—psoriasis	5.42e-05	0.000288	CcSEcCtD
Estropipate—Headache—Prednisolone—psoriasis	5.42e-05	0.000288	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—JUN—psoriasis	5.42e-05	0.00343	CbGpPWpGaD
Estropipate—Constipation—Prednisone—psoriasis	5.38e-05	0.000286	CcSEcCtD
Estropipate—Vomiting—Hydrocortisone—psoriasis	5.38e-05	0.000286	CcSEcCtD
Estropipate—Rash—Hydrocortisone—psoriasis	5.33e-05	0.000284	CcSEcCtD
Estropipate—Dermatitis—Hydrocortisone—psoriasis	5.33e-05	0.000283	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—JUN—psoriasis	5.31e-05	0.00336	CbGpPWpGaD
Estropipate—Headache—Hydrocortisone—psoriasis	5.3e-05	0.000282	CcSEcCtD
Estropipate—Dizziness—Triamcinolone—psoriasis	5.26e-05	0.00028	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—psoriasis	5.26e-05	0.00028	CcSEcCtD
Estropipate—Infection—Methotrexate—psoriasis	5.22e-05	0.000278	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.22e-05	0.00331	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—JUN—psoriasis	5.19e-05	0.00329	CbGpPWpGaD
Estropipate—Asthenia—Betamethasone—psoriasis	5.18e-05	0.000276	CcSEcCtD
Estropipate—Asthenia—Dexamethasone—psoriasis	5.18e-05	0.000276	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—psoriasis	5.16e-05	0.000274	CcSEcCtD
Estropipate—Gastrointestinal pain—Prednisone—psoriasis	5.14e-05	0.000274	CcSEcCtD
Estropipate—Nausea—Prednisolone—psoriasis	5.14e-05	0.000274	CcSEcCtD
Estropipate—Pruritus—Dexamethasone—psoriasis	5.11e-05	0.000272	CcSEcCtD
Estropipate—Pruritus—Betamethasone—psoriasis	5.11e-05	0.000272	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—NFKB1—psoriasis	5.11e-05	0.00324	CbGpPWpGaD
Estropipate—Skin disorder—Methotrexate—psoriasis	5.11e-05	0.000272	CcSEcCtD
Estropipate—Vomiting—Triamcinolone—psoriasis	5.06e-05	0.000269	CcSEcCtD
Estropipate—ESR1—LKB1 signaling events—TP53—psoriasis	5.06e-05	0.0032	CbGpPWpGaD
Estropipate—Nausea—Hydrocortisone—psoriasis	5.02e-05	0.000267	CcSEcCtD
Estropipate—Rash—Triamcinolone—psoriasis	5.02e-05	0.000267	CcSEcCtD
Estropipate—Dermatitis—Triamcinolone—psoriasis	5.02e-05	0.000267	CcSEcCtD
Estropipate—Urticaria—Prednisone—psoriasis	5e-05	0.000266	CcSEcCtD
Estropipate—ALB—Folate Metabolism—ICAM1—psoriasis	4.99e-05	0.00316	CbGpPWpGaD
Estropipate—Headache—Triamcinolone—psoriasis	4.99e-05	0.000265	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—psoriasis	4.97e-05	0.000265	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—psoriasis	4.97e-05	0.000265	CcSEcCtD
Estropipate—Diarrhoea—Dexamethasone—psoriasis	4.94e-05	0.000263	CcSEcCtD
Estropipate—Diarrhoea—Betamethasone—psoriasis	4.94e-05	0.000263	CcSEcCtD
Estropipate—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.93e-05	0.00312	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Methotrexate—psoriasis	4.79e-05	0.000255	CcSEcCtD
Estropipate—Dizziness—Dexamethasone—psoriasis	4.78e-05	0.000254	CcSEcCtD
Estropipate—Dizziness—Betamethasone—psoriasis	4.78e-05	0.000254	CcSEcCtD
Estropipate—Insomnia—Methotrexate—psoriasis	4.76e-05	0.000253	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.73e-05	0.003	CbGpPWpGaD
Estropipate—Nausea—Triamcinolone—psoriasis	4.73e-05	0.000252	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—NFKB1—psoriasis	4.72e-05	0.00299	CbGpPWpGaD
Estropipate—Paraesthesia—Methotrexate—psoriasis	4.72e-05	0.000251	CcSEcCtD
Estropipate—Somnolence—Methotrexate—psoriasis	4.67e-05	0.000249	CcSEcCtD
Estropipate—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	4.67e-05	0.00296	CbGpPWpGaD
Estropipate—Hypersensitivity—Prednisone—psoriasis	4.64e-05	0.000247	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—VDR—psoriasis	4.63e-05	0.00293	CbGpPWpGaD
Estropipate—Dyspepsia—Methotrexate—psoriasis	4.63e-05	0.000246	CcSEcCtD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.62e-05	0.00293	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.61e-05	0.00292	CbGpPWpGaD
Estropipate—Vomiting—Dexamethasone—psoriasis	4.59e-05	0.000244	CcSEcCtD
Estropipate—Vomiting—Betamethasone—psoriasis	4.59e-05	0.000244	CcSEcCtD
Estropipate—Rash—Dexamethasone—psoriasis	4.55e-05	0.000242	CcSEcCtD
Estropipate—Rash—Betamethasone—psoriasis	4.55e-05	0.000242	CcSEcCtD
Estropipate—Dermatitis—Betamethasone—psoriasis	4.55e-05	0.000242	CcSEcCtD
Estropipate—Dermatitis—Dexamethasone—psoriasis	4.55e-05	0.000242	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—psoriasis	4.54e-05	0.000241	CcSEcCtD
Estropipate—Fatigue—Methotrexate—psoriasis	4.53e-05	0.000241	CcSEcCtD
Estropipate—Headache—Dexamethasone—psoriasis	4.53e-05	0.000241	CcSEcCtD
Estropipate—Headache—Betamethasone—psoriasis	4.53e-05	0.000241	CcSEcCtD
Estropipate—Asthenia—Prednisone—psoriasis	4.51e-05	0.00024	CcSEcCtD
Estropipate—Pain—Methotrexate—psoriasis	4.5e-05	0.000239	CcSEcCtD
Estropipate—Pruritus—Prednisone—psoriasis	4.45e-05	0.000237	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.44e-05	0.00281	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—CRP—psoriasis	4.31e-05	0.00273	CbGpPWpGaD
Estropipate—Diarrhoea—Prednisone—psoriasis	4.3e-05	0.000229	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—psoriasis	4.3e-05	0.000229	CcSEcCtD
Estropipate—Nausea—Dexamethasone—psoriasis	4.29e-05	0.000228	CcSEcCtD
Estropipate—Nausea—Betamethasone—psoriasis	4.29e-05	0.000228	CcSEcCtD
Estropipate—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.27e-05	0.00271	CbGpPWpGaD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.25e-05	0.00269	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—STAT3—psoriasis	4.25e-05	0.00269	CbGpPWpGaD
Estropipate—Urticaria—Methotrexate—psoriasis	4.18e-05	0.000222	CcSEcCtD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.17e-05	0.00264	CbGpPWpGaD
Estropipate—Dizziness—Prednisone—psoriasis	4.16e-05	0.000221	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—psoriasis	4.16e-05	0.000221	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—psoriasis	4.16e-05	0.000221	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—TNF—psoriasis	4.06e-05	0.00257	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.03e-05	0.00255	CbGpPWpGaD
Estropipate—Vomiting—Prednisone—psoriasis	4e-05	0.000213	CcSEcCtD
Estropipate—Rash—Prednisone—psoriasis	3.97e-05	0.000211	CcSEcCtD
Estropipate—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.97e-05	0.00251	CbGpPWpGaD
Estropipate—Dermatitis—Prednisone—psoriasis	3.96e-05	0.000211	CcSEcCtD
Estropipate—Headache—Prednisone—psoriasis	3.94e-05	0.00021	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—CARM1—psoriasis	3.91e-05	0.00248	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—CP—psoriasis	3.89e-05	0.00247	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	3.88e-05	0.00246	CbGpPWpGaD
Estropipate—Hypersensitivity—Methotrexate—psoriasis	3.87e-05	0.000206	CcSEcCtD
Estropipate—ALB—Folate Metabolism—IFNG—psoriasis	3.8e-05	0.00241	CbGpPWpGaD
Estropipate—Asthenia—Methotrexate—psoriasis	3.77e-05	0.000201	CcSEcCtD
Estropipate—Nausea—Prednisone—psoriasis	3.74e-05	0.000199	CcSEcCtD
Estropipate—ESR2—Gene Expression—CARM1—psoriasis	3.73e-05	0.00237	CbGpPWpGaD
Estropipate—Pruritus—Methotrexate—psoriasis	3.72e-05	0.000198	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—psoriasis	3.6e-05	0.000191	CcSEcCtD
Estropipate—ESR1—ATF-2 transcription factor network—IL6—psoriasis	3.59e-05	0.00228	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.55e-05	0.00225	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.5e-05	0.00222	CbGpPWpGaD
Estropipate—Dizziness—Methotrexate—psoriasis	3.48e-05	0.000185	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.45e-05	0.00219	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—TYK2—psoriasis	3.45e-05	0.00218	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—psoriasis	3.42e-05	0.00217	CbGpPWpGaD
Estropipate—Vomiting—Methotrexate—psoriasis	3.34e-05	0.000178	CcSEcCtD
Estropipate—Rash—Methotrexate—psoriasis	3.32e-05	0.000176	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—psoriasis	3.31e-05	0.000176	CcSEcCtD
Estropipate—Headache—Methotrexate—psoriasis	3.29e-05	0.000175	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—IL6—psoriasis	3.27e-05	0.00208	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—PPARG—psoriasis	3.23e-05	0.00205	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NDUFA5—psoriasis	3.18e-05	0.00202	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—NFKB1—psoriasis	3.16e-05	0.002	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—IL6—psoriasis	3.13e-05	0.00199	CbGpPWpGaD
Estropipate—Nausea—Methotrexate—psoriasis	3.12e-05	0.000166	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.07e-05	0.00194	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.04e-05	0.00193	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.02e-05	0.00192	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.02e-05	0.00191	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	2.96e-05	0.00187	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.95e-05	0.00187	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.82e-05	0.00179	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.8e-05	0.00178	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HCAR2—psoriasis	2.77e-05	0.00176	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CYP2S1—psoriasis	2.71e-05	0.00171	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.7e-05	0.00171	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.68e-05	0.0017	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.51e-05	0.00159	CbGpPWpGaD
Estropipate—ALB—Platelet degranulation—VEGFA—psoriasis	2.46e-05	0.00156	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TNF—psoriasis	2.46e-05	0.00156	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.45e-05	0.00155	CbGpPWpGaD
Estropipate—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.44e-05	0.00155	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TAGAP—psoriasis	2.4e-05	0.00152	CbGpPWpGaD
Estropipate—ALB—Hemostasis—ITGAL—psoriasis	2.37e-05	0.0015	CbGpPWpGaD
Estropipate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.34e-05	0.00148	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—VDR—psoriasis	2.33e-05	0.00148	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.32e-05	0.00147	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.3e-05	0.00145	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.3e-05	0.00145	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.24e-05	0.00142	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—VDR—psoriasis	2.23e-05	0.00141	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—psoriasis	2.17e-05	0.00137	CbGpPWpGaD
Estropipate—ALB—Metabolism—NDUFA5—psoriasis	2.13e-05	0.00135	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.03e-05	0.00129	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.98e-05	0.00126	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—IL6—psoriasis	1.98e-05	0.00126	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.98e-05	0.00125	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.95e-05	0.00124	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.89e-05	0.0012	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CARM1—psoriasis	1.88e-05	0.00119	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.85e-05	0.00117	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYP2S1—psoriasis	1.81e-05	0.00115	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NDUFA5—psoriasis	1.74e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.74e-05	0.0011	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—IL6—psoriasis	1.69e-05	0.00107	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—PPARG—psoriasis	1.63e-05	0.00103	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.62e-05	0.00103	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.58e-05	0.000999	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PPARG—psoriasis	1.55e-05	0.000985	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.53e-05	0.000972	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NDUFA5—psoriasis	1.49e-05	0.000944	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYP2S1—psoriasis	1.48e-05	0.000939	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL20—psoriasis	1.44e-05	0.000912	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.39e-05	0.00088	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CARM1—psoriasis	1.32e-05	0.000837	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYP2S1—psoriasis	1.27e-05	0.000802	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NDUFA5—psoriasis	1.15e-05	0.000728	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—VDR—psoriasis	1.12e-05	0.000712	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.09e-05	0.000691	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYP2S1—psoriasis	9.77e-06	0.000619	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NOS2—psoriasis	9.71e-06	0.000615	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.48e-06	0.000601	CbGpPWpGaD
Estropipate—ALB—Metabolism—CARM1—psoriasis	8.84e-06	0.00056	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.26e-06	0.000524	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CAT—psoriasis	8.13e-06	0.000515	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SOCS1—psoriasis	7.93e-06	0.000502	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—psoriasis	7.84e-06	0.000497	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.76e-06	0.000492	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CARM1—psoriasis	7.23e-06	0.000459	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.76e-06	0.000429	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.63e-06	0.00042	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—APOE—psoriasis	6.31e-06	0.0004	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CARM1—psoriasis	6.18e-06	0.000392	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—LEP—psoriasis	5.85e-06	0.000371	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—APOE—psoriasis	5.85e-06	0.000371	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.78e-06	0.000366	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—psoriasis	5.62e-06	0.000356	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—psoriasis	5.5e-06	0.000349	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NFKBIA—psoriasis	5.45e-06	0.000345	CbGpPWpGaD
Estropipate—ALB—Metabolism—CAT—psoriasis	5.44e-06	0.000345	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CARM1—psoriasis	4.77e-06	0.000302	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TYK2—psoriasis	4.46e-06	0.000283	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CAT—psoriasis	4.45e-06	0.000282	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—psoriasis	4.25e-06	0.000269	CbGpPWpGaD
Estropipate—ALB—Metabolism—APOE—psoriasis	4.22e-06	0.000268	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CXCL8—psoriasis	3.89e-06	0.000246	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CAT—psoriasis	3.8e-06	0.000241	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—psoriasis	3.68e-06	0.000233	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—psoriasis	3.61e-06	0.000229	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NFKB1—psoriasis	3.48e-06	0.00022	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—APOE—psoriasis	3.46e-06	0.000219	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—psoriasis	3.16e-06	0.0002	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—psoriasis	3.13e-06	0.000198	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—psoriasis	3.01e-06	0.000191	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—APOE—psoriasis	2.95e-06	0.000187	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CAT—psoriasis	2.93e-06	0.000186	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—psoriasis	2.57e-06	0.000163	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—psoriasis	2.39e-06	0.000151	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—APOE—psoriasis	2.28e-06	0.000145	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—psoriasis	2.18e-06	0.000138	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—psoriasis	1.99e-06	0.000126	CbGpPWpGaD
